2011- Research associate (CR1), Inserm U698, Paris, France
2009-2011 Research associate (CR1), Inserm U779, Le Kremlin-Bicêtre, France
2005-2009 Research associate (CR2), Inserm U779, Le Kremlin-Bicêtre, France
2004-2005 Project Leader, Nanovec Project, Paris, France
2003-2005 Scientific Leader, Stopoison Start-Up, Paris, France
1999-2003 PhD Student in Pharmaceutical Sciences, University Paris 11, France (Pr. D. Labarre & Dr. C. Vauthier)
He was trained as Physico-Chemist. In 2003, he received his PhD in Pharmaceutical Sciences from the University Paris 11 on polymer nanoparticles. He joined Stopoison Start-up in 2003 as Scientific Leader to develop detoxifying multiple emulsions (Paris, France). He was awarded a grant from the French Ministry of Research for his Nanovec project based on nanotechnology in 2005. He joined Inserm as a Research associate (CR2) in 2005 to conduct research on blood substitute based on nanoparticles (U779, Le Kremlin-Bicêtre, Frannce). Since 2011, he has been conducting research on theranostic nanomedicine applied to atherothrombotic diseases (U698, Paris, France).